- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
You are here
Trial Summary Table
Trial Name | Phase | Start Date | Sponsors | Countries | Population | Candidate(s) | Status | Expected Completion Date |
---|---|---|---|---|---|---|---|---|
Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian transgender women (PrEParadas) | Demo Project | Thursday, July 12, 2018 | Brazilian Ministry of Health | Brazil | Ongoing | July 2020 | ||
Impower 022 | III | Wednesday, February 24, 2021 | Merck Sharp & Dohme Corp. | United States of America, South Africa | Women | Islatravir (MK-8591), TDF/FTC (Truvada) | Stopped Early | July 2024 |
Impower 024 | III | Monday, March 15, 2021 | Merck Sharp & Dohme Corp. | Men, MSM, Transgender women | Islatravir (MK-8591) | Stopped Early | September 2024 | |
IPERGAY | III | Wednesday, February 22, 2012 | French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS), the Canadian Trial network, Bill and Melinda Gates Foundation, Fondation Pierre Bergé, Gilead Sciences | Canada, France | MSM | TDF/FTC (Truvada) | Completed | June 2016 |
IPM 056 / CCN019B | I/II | Wednesday, June 1, 2022 | IPM, NICHD, NIH | United States of America | Women | Dapivirine-Levonorgestrel ring | Ongoing | September 2023 |
iPrEx | III | Saturday, June 30, 2007 | Bill & Melinda Gates Foundation, NIAID | United States of America, Brazil, Ecuador, Peru, South Africa, Thailand | MSM | TDF/FTC (Truvada) | Completed | February 2014 |
iPrEx OLE | Open Label | Saturday, July 9, 2011 | DAIDS/NIH, through a grant to the Gladstone Institutes | Peru, United States of America, Brazil, Thailand, South Africa, Ecuador | MSM | TDF/FTC (Truvada) | Completed | April 2014 |
Ireland Demonstration Project | Demo Project | Sunday, December 18, 2016 | Ireland | Planned | December 2017 | |||
LAC PATH PrEP Demo Project | Demo Project | California HIV/AIDS Research Program of the University of California; LA County HIV & STD Program; Los Angeles Gay and Lesbian Center; OASIS Clinic; AIDS Project LA; UCLA | United States of America | MSM | TDF/FTC (Truvada) | Completed | May 2017 | |
LVCT Health and SWOP Kenya (IPCP - Kenya) | Demo Project | Saturday, August 1, 2015 | Bill & Melinda Gates Foundation | Kenya | Women, Men, MSM | Ongoing | April 2017 |